ALPS Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-99,164
| Closed | -$1.93M | – | 997 |
|
|
2018
Q1 | $1.93M | Buy |
99,164
+17,038
| +21% | +$331K | 0.02% | 214 |
|
|
2017
Q4 | $1.37M | Buy |
82,126
+8,940
| +12% | +$149K | 0.01% | 219 |
|
|
2017
Q3 | $1.49M | Buy |
73,186
+6,661
| +10% | +$135K | 0.01% | 208 |
|
|
2017
Q2 | $1.07M | Buy |
66,525
+3,079
| +5% | +$49.6K | 0.01% | 224 |
|
|
2017
Q1 | $803K | Sell |
63,446
-7,554
| -11% | -$95.6K | 0.01% | 238 |
|
|
2016
Q4 | $941K | Sell |
71,000
-23,158
| -25% | -$307K | 0.01% | 224 |
|
|
2016
Q3 | $2.23M | Sell |
94,158
-9,535
| -9% | -$226K | 0.02% | 179 |
|
|
2016
Q2 | $2.99M | Buy |
103,693
+22,043
| +27% | +$635K | 0.03% | 151 |
|
|
2016
Q1 | $2.61M | Sell |
81,650
-11,242
| -12% | -$360K | 0.03% | 143 |
|
|
2015
Q4 | $3.97M | Sell |
92,892
-20,282
| -18% | -$867K | 0.04% | 130 |
|
|
2015
Q3 | $39.8K | Buy |
113,174
+42,001
| +59% | +$14.8K | 0.04% | 126 |
|
|
2015
Q2 | $3.27M | Buy |
71,173
+35,748
| +101% | +$1.64M | 0.03% | 140 |
|
|
2015
Q1 | $1.66M | Buy |
+35,425
| New | +$1.66M | 0.01% | 157 |
|